<?xml version="1.0" encoding="UTF-8"?>
<p>The isolated compound 
 <bold>202</bold> was preliminary evaluated for its cytotoxicities against MCF-7, NCI-H460, HepG-2, and SF-268 cell lines with cisplatin as the positive control. The new compound 
 <bold>202</bold> exhibited weak growth inhibitory activity against the tumor cell lines MCF-7 and HepG-2 with IC
 <sub>50</sub> values of 70 and 60 ÂµM, respectively [
 <xref rid="B64-ijms-22-00959" ref-type="bibr">64</xref>].
</p>
